New procedure codes in Belgian Nomenclature came into force in March 2020

08

Apr 2020

In March 2020, the Nomenclature was updated. The update brought changes regarding the creation of new codes, deletion of codes, modification of existing codes, and reimbursement conditions.

The health benefit Nomenclature of the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) includes the services (with specific hospital and ambulatory codes) that are reimbursed by the compulsory health care insurance, wholly or partially. The Nomenclature and its changes are published in the Belgian Official Gazette.

The changes of the following articles of the Nomenclature come into force on March 1, 2020:

Key changes in the General (1) article:

  • Modifications of §8 regarding the period of essential medical documentation keeping – it should be at least five years (reports, documents, plots, graphics mentioned in the nomenclature, X-ray and laboratory analysis results)

Key changes in the Otorhinolaryngology (14) article:

  • Modifications of existing codes were made (video head impulse test, VHIT) was added to the labyrinth examination 257611-257622)
  • New reimbursement conditions were added

Key changes in the Radiology (17) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Radiotherapy and radium therapy – nuclear medicine (18) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Clinical biology (24) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Anatomical pathology (32) article:

  • The following code was added:

589853-589864 “Fees for cytopathological screening examination for neoplastic cells in cervico-vaginal sample, using the liquid phase cytology, regardless of the number of samples”

  • Modifications of existing codes were made
  • One code was removed - 588350 – 588361
  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Genetic examinations (33) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more